Prevalence and determinants of hypertension in Lomé (Togo): Results of a screening in May 2011;Prévalence de l'hypertension artérielle et description de ses facteurs de risque à Lomé (Togo) : Résultats d'un dépistage réalisé dans la population générale en m

Annales de Cardiologie et d'Angeiologie

Volumn 62, Issue 1, 2013, Pages 43-50

  Yayehd, K ^a,b   Damorou, F ^a,b   Akakpo, R ^a   Tcherou T ^a,b   N'Da, N W ^a,b   Pessinaba, S ^a,b   Belle, L ^c   Johnson, A ^a,b  

^a UNIVERSITÉ DE LOMÉ   (Togo)

^b Programme national de lutte contre les maladies cardiovasculaires   (Togo)

^c Centre Hospitalier de la Region d'Annecy   (France)

Author keywords

Arterial hypertension; Lom ; Prevalence; Risk factors

Indexed keywords

AGE; ARTICLE; AWARENESS; BODY MASS; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL CONTRACEPTION; PREVALENCE; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SALT INTAKE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TOGO; WAIST CIRCUMFERENCE;

AGE FACTORS; BODY MASS INDEX; CONTRACEPTIVES, ORAL; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; FEMALE; HEALTH EDUCATION; HEALTH SURVEYS; HUMANS; HYPERTENSION; MALE; MASS SCREENING; OBESITY; POVERTY; QUESTIONNAIRES; RISK FACTORS; SEX FACTORS; SODIUM, DIETARY; TOGO; WAIST CIRCUMFERENCE;

EID: 84873748290     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2012.09.006     Document Type: Article

References (38)

1. Barylski M., Małyszko J., Rysz J., MyŚliwiec M., Banach M. Lipids, blood pressure, kidney - What was new in 2011?. Arch Med Sci 2011, 7:1055-1066.
2. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., He J. Global burden of hypertension analysis of world wide data. Lancet 2005, 365:217-223.
3. Bielecka-Dabrowa A., Aronow W.S., Rysz J., Banach M. The rise and fall of hypertension: lessons learned from Eastern Europe. Curr Cardiovasc Risk Rep 2011, 5:174-179.
4. Donnan G.A., Fisher M., Macleod M., David S.M. Stroke. Lancet 2008, 371:1612-1623.
5. Banach M., Mikhailidis D.P., Kjeldsen S.E., Rysz J. Time for new indications for statins?. Med Sci Monit 2009, 15:MS1-MS5.
6. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. The seventh report of the JNC on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 2003, 289:2560-2572.
7. Gradman A.H., Basile J.N., Carter B.L., Bakris G.L. American Society of Hypertension Writing Group. Combination therapy in hypertension. J Clin Hypertens (Greenwich) 2011, 13:146-154.
8. Ramezani M.A., Dastanpour M., Eshaghi S.R., et al. Determinants of awareness, treatment and control of hypertension in Isfahan, Central Iran. Arch Med Sci 2009, 5:523-530.
9. Damorou F., Pessinaba S., Tchérou T., Yayehd K., Ndassa S.M.C., Soussou B. Hypertension artérielle du sujet noir âgé de 50ans et plus à Lomé: aspects épidémiologiques et évaluation du risque cardiovasculaire (étude prospective et longitudinale de 1485 patients). Ann Cardiol Angeiol (Paris) 2011, 60:61-66.
10. 4e Recensement général de la population togolaise et de l'habitat, novembre 2011. Disponible en ligne à l'adresse : Mise à jour le 15.02.2012. http://www.stat-togo.org/index.php%3F.
11. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-1187.
12. Guidelines subcommittee 1999 World Health Organization-Internal Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999, 17:151-183.
13. WHO Obesity: preventing and managing the global epidemic. WHO Technical Report Series number 894. World Health Organ Tech Rep Ser 2000, 894:i-xii. [1-253].
14. Alberti K.G.M.M., Zimmet P., Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005, 366:1059-1062.
15. Niakara A., Nebie L.V.A., Zague N.M., Ouedraogo N.A., Megnibeto A.C. Connaissances d'une population urbaine sur l'HTA : enquête prospective menée à Ouagadougou, Burkina-Faso. Bull Soc Pathol Exot 2003, 96:219-222.
16. Kimbally-Kaky G., Gombet T., Bolanda J.D., VoumboY, Okili B., Ellenga-Mbolla B., et al. Prévalence de l'hypertension artérielle à Brazzaville. Cardiol Trop 2006, 32:43-46.
17. Edwards R., Unwin N., Mugusi F. Hypertension prevalence and care in an urban and rural area of Tanzania. J Hypertens 2000, 18:145-152.
18. Godet-Thobie H., Vernay M., Noukpoape A., Salanave B., Malon A., Castetbon K. Niveau tensionnel moyen et prévalence de l'hypertension artérielle chez les adultes de 18 à 74 ans. ENNS 2006-2007. BEH Thematique 2008, 49-50:478-483.
19. Comlan P, Ayenengoye C, Baye E, Ecke E, Ezinah F, Ngoungou E. Enquête sur les facteurs de risque des maladies non transmissibles à Libreville et Owendo. Libreville, le 23 juin 2009. Disponible à l'adresse : http://www.who.int/chp/steps/2009_STEPS_Report_Gabon.pdf.
20. Hajjar I., Kotchen J.M., Kotchen T.A. Hypertension: trends in prevalence, incidence and control. Annu Rev Public Health 2006, 27:465-490.
21. McKeown R.E. The epidemiologic transition: changing patterns of mortality and population dynamics. Am J Lifestyle Med 2009, 3:19S-26S.
22. Initiative for cardiovascular health research in the developing countries. Disponible à l'adresse : http://www.ichealth.org/.
23. Mbewu A., Mbanya J.C. Cardiovascular disease. Disease and mortality in Sub-Saharan Africa 2006, World Bank, Washington (DC), [Chapter 21. http://www.ncbi.nlm.nih.gov/books/NBK2294/]. 2nd ed. D.T. Jamison, R.G. Feachem, M.W. Makgoba, E.R. Bos, F.K. Baingana, K.J. Hofman (Eds.).
24. Steyn K., Gaziano A., Bradshaw D., Laubscher R., Fourie J. Hypertension in South African adults: results from the demographic and health survey-1998. J Hypertens 2001, 19:1717-1725.
25. Cooper R., Rotimi C., Ataman S., McGee D., Osotimehin B., Kadiri S., et al. The prevalence of hypertension in seven populations of West African origin. Am J Public Health 1997, 87:160-168.
26. Rabarijaona L., Rakotomalala D.P., Rakotonirina El C., Rakotoarimana S., Randrianasolo O. Prévalence et sévérité de l'HTA de l'adulte en milieu urbain à Antananarivo. Rev Anesth Rea Med Urg 2009, 1:24-27.
27. Longo-Mbenza Beya E, Ekwanzala Vangu N, Nahimana D, Mbungu F. Enquête sur les facteurs de risque des maladies non transmissibles à Kinshasa. étude STEPS. Disponible sur le net à l'adresse : http://www.who.int/chp/steps/STEPS_DRC_Final.pdf.%202006.
28. Brito M.B., Nobre F., Vieira C.S. Hormonal contraception and cardiovascular system. Arq Bras Cardiol 2011, 96:e81-e89.
29. Nakanishi N., Makino K., Nishina K., Suzuki K., Tatara K. Relationship of light to moderate alcohol consumption and risk of hypertension in Japanese male office workers. Alcohol Clin Exp Res 2002, 26:988-994.
30. Yoshita K., Miura K., Morikawa Y., Ishizaki M., Kido T., Naruse Y., et al. Relationship of alcohol consumption to 7-year blood pressure change in Japanese men. J Hypertens 2005, 23:1485-1490.
31. Shafey O., Eriksen M., Ross H., Mackay J. The Tobacco Atlas 2009, American Cancer Society, Atlanta. 3rd ed.
32. Ezzati M., Henley S.J., Thun M.J., Lopez A.D. Role of smoking in global and regional cardiovascular mortality. Circulation 2005, 112:489.
33. Poterico J.A., Stanojevic S., Ruiz-Grosso P., Bernabe-Ortiz A., Miranda J.J. The association between socioeconomic status and obesity in Peruvian women. Obesity (Silver Spring) 2011, 10.1038/oby.2011.288.
34. Yusuf S., Hawken S., Ounpuu S. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.
35. Victor R.G. Systemic hypertension mechanisms and diagnosis: definition, prevalence, variability, and determinants of hypertension. Braunwald's heart disease - A textbook of cardiovascular medicine 2011, 935-936. Elsevier Saunders, Boston. 9th ed. R.O. Bonow, D.L. Mann, D.P. Zipes, P. Libby (Eds.).
36. Ulasi I., Ijoma C., Onwubere B., Arodiwe E., Onodugo O., Okafor C. High prevalence and low awareness of hypertension in a market population in Enugu, Nigeria. Int J Hypertens 2011, 11:365. [doi:10.1186/1471-2458-11-365].
37. Taylor R.S., Ashton K.E., Moxham T., Hooper L., Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review). Am J Hypertens 2011, 24:843.
38. Curtis K.M., Mohllajee A.P., Martins S.L., Peterson H.B. Combined oral contraceptive use among women with hypertension: a systematic review. Contraception 2006, 73:179-188.